02:21 PM EDT, 09/25/2024 (MT Newswires) -- MetLife ( MET ) got a favorable decision from the US Court of Appeals for the Third Circuit Wednesday in a case by former employees blaming the company for mismanaging their health plan and taking $65 million in drug rebates.

The court ruled that MetLife ( MET ) employees lacked standing to sue for improperly withheld rebate money, finding they couldn't prove injury and establish standing to sue or establish a right to the funds.

The employees' claim that MetLife's ( MET ) retention of the funds caused them to pay more for their insurance is "speculative," according to the ruling.

MetLife ( MET ) did not immediately respond to MT Newswires' request for comment.

Price: 81.01, Change: +0.55, Percent Change: +0.69